Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.

Thakkar V, Stevens W, Prior D, Rabusa C, Sahhar J, Walker JG, Roddy J, Lester S, Rischmueller M, Zochling J, Nash P, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Clin Exp Rheumatol. 2016 May 23. [Epub ahead of print]

PMID:
27214686
2.

Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy.

Vasu S, Wu H, Satoskar A, Puto M, Roddy J, Blum W, Klisovic R, Andritsos L, Hofmeister C, Benson DM, Efebera Y, Jaglowski S, Penza S, Cohen D, Devine S, Cataland S.

Bone Marrow Transplant. 2016 Apr 11. doi: 10.1038/bmt.2016.87. [Epub ahead of print] No abstract available.

PMID:
27064689
3.

Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.

Owen C, Ngian GS, Elford K, Moore O, Stevens W, Nikpour M, Rabusa C, Proudman S, Roddy J, Zochling J, Hill C, Sturgess A, Tymms K, Youssef P, Sahhar J.

Clin Exp Rheumatol. 2016 Mar 24. [Epub ahead of print]

PMID:
27049330
4.

Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis.

Quinlivan A, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, Youssef P, Gabbay E, Roddy J, Walker JG, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Intern Med J. 2015 Nov;45(11):1134-40. doi: 10.1111/imj.12890.

PMID:
26337683
5.

Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.

Patterson KA, Roberts-Thomson PJ, Lester S, Tan JA, Hakendorf P, Rischmueller M, Zochling J, Sahhar J, Nash P, Roddy J, Hill C, Nikpour M, Stevens W, Proudman SM, Walker JG.

Arthritis Rheumatol. 2015 Dec;67(12):3234-44. doi: 10.1002/art.39316.

PMID:
26246178
6.

Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease.

Moore OA, Proudman SM, Goh N, Corte TJ, Rouse H, Hennessy O, Morrisroe K, Thakkar V, Sahhar J, Roddy J, Youssef P, Gabbay E, Nash P, Zochling J, Stevens W, Nikpour M.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S111-6. Epub 2015 Aug 5.

PMID:
26243401
7.

Tocilizumab for steroid refractory acute graft-versus-host disease.

Roddy JV, Haverkos BM, McBride A, Leininger KM, Jaglowski S, Penza S, Klisovic R, Blum W, Vasu S, Hofmeister CC, Benson DM, Andritsos LA, Devine SM, Efebera YA.

Leuk Lymphoma. 2016;57(1):81-5. doi: 10.3109/10428194.2015.1045896. Epub 2015 Jul 3.

8.

Cost analysis of long-term outcomes of an urban mental health court.

Kubiak S, Roddy J, Comartin E, Tillander E.

Eval Program Plann. 2015 Oct;52:96-106. doi: 10.1016/j.evalprogplan.2015.04.002. Epub 2015 May 2.

PMID:
25982871
9.

Streets, strolls and spots: sex work, drug use and social space in Detroit.

Draus P, Roddy J, Asabigi K.

Int J Drug Policy. 2015 May;26(5):453-60. doi: 10.1016/j.drugpo.2015.01.004. Epub 2015 Feb 4.

PMID:
25736572
10.

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis.

Hao Y, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, Youssef P, Gabbay E, Roddy J, Walker J, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Arthritis Res Ther. 2015 Jan 18;17:7. doi: 10.1186/s13075-015-0517-5.

11.

An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3.

Zochling J, Newell F, Charlesworth JC, Leo P, Stankovich J, Cortes A, Zhou Y, Stevens W, Sahhar J, Roddy J, Nash P, Tymms K, Rischmueller M, Lester S, Proudman S, Brown MA.

Arthritis Res Ther. 2014 Oct 21;16(5):438. doi: 10.1186/s13075-014-0438-8.

12.

Making sense of the transition from the Detroit streets to drug treatment.

Draus P, Roddy J, Asabigi K.

Qual Health Res. 2015 Feb;25(2):228-40. doi: 10.1177/1049732314552454. Epub 2014 Sep 22.

PMID:
25246332
13.

The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis.

Morrisroe KB, Stevens W, Nandurkar H, Prior D, Thakkar V, Roddy J, Zochling J, Sahhar J, Tymms K, Sturgess A, Major G, Kermeen F, Hill C, Walker J, Nash P, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-133-7. Epub 2014 Feb 24.

PMID:
24564981
14.

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.

Thakkar V, Stevens W, Prior D, Youssef P, Liew D, Gabbay E, Roddy J, Walker JG, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Arthritis Res Ther. 2013;15(6):R193.

15.

Metabolic evaluation of urolithiasis and obesity in a midwestern pediatric population.

Roddy JT, Ghousheh AI, Christensen MA, Durkee CT.

J Urol. 2014 Mar;191(3):771-6. doi: 10.1016/j.juro.2013.09.064. Epub 2013 Oct 3.

PMID:
24095904
16.

A systematic review of ultrasonography as an outcome measure of skin involvement in systemic sclerosis.

Ch'ng SS, Roddy J, Keen HI.

Int J Rheum Dis. 2013 Jun;16(3):264-72. doi: 10.1111/1756-185X.12106. Review.

PMID:
23981746
17.

Urolithiasis in patients on high dose felbamate.

Ghousheh AI, Groth TW, Fryjoff KM, Wille DF, Mandel NS, Roddy JT, Durkee CT.

J Urol. 2013 May;189(5):1865-9. doi: 10.1016/j.juro.2012.12.032. Epub 2012 Dec 21.

PMID:
23262038
18.

Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance.

Salmon D, Yih WK, Lee G, Rosofsky R, Brown J, Vannice K, Tokars J, Roddy J, Ball R, Gellin B, Lurie N, Koh H, Platt R, Lieu T; PRISM Program Group.

Health Aff (Millwood). 2012 Nov;31(11):2518-27. doi: 10.1377/hlthaff.2012.0104.

19.

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease.

Moore OA, Goh N, Corte T, Rouse H, Hennessy O, Thakkar V, Byron J, Sahhar J, Roddy J, Gabbay E, Youssef P, Nash P, Zochling J, Proudman SM, Stevens W, Nikpour M.

Rheumatology (Oxford). 2013 Jan;52(1):155-60. doi: 10.1093/rheumatology/kes289. Epub 2012 Oct 13.

20.

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study.

Ngian GS, Stevens W, Prior D, Gabbay E, Roddy J, Tran A, Minson R, Hill C, Chow K, Sahhar J, Proudman S, Nikpour M.

Arthritis Res Ther. 2012 Oct 5;14(5):R213. doi: 10.1186/ar4051.

Items per page

Supplemental Content

Write to the Help Desk